Xiaozhen Lin
Impact in
Papers in
-
- RNA modifications and cancer 2
-
- Parkinson's Disease Mechanisms and Treatments 3
- Neurological disorders and treatments 2
- Botulinum Toxin and Related Neurological Disorders 2
- Co-authors
- Bin Qiao (1 shared paper)Baoxia He (1 shared paper)Gang Liang (1 shared paper)Anzhou Tang (1 shared paper)Li Li (1 shared paper)Zhiming Huang (1 shared paper)Qingdi Quentin Li (1 shared paper)Su Zhang (1 shared paper)
In The Last Decade
Xiaozhen Lin
27 papers receiving 483 citations
Peers
Comparison fields: 5 of 88
- Applied Microbiology and Biotechnology 18
- Energy Engineering and Power Technology 18
- Biochemistry 29
- Cancer Research 66
- Genetics 44
Countries citing papers authored by Xiaozhen Lin
This map shows the geographic impact of Xiaozhen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhen Lin more than expected).
Fields of papers citing papers by Xiaozhen Lin
This network shows the impact of papers produced by Xiaozhen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhen Lin. The network helps show where Xiaozhen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaozhen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. | 2010 | 123 |
| 2 | 2017 | 90 | |
| 3 | 2022 | 46 | |
| 4 | 2013 | 42 | |
| 5 | 2015 | 29 | |
| 6 | 2023 | 26 | |
| 7 | 2015 | 17 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 11 | |
| 11 | 2013 | 11 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2023 | 7 | |
| 15 | 2017 | 7 | |
| 16 | 2019 | 6 | |
| 17 | [Efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in preschool and school-age children with allergic asthma and allergic rhinitis]. | 2013 | 6 |
| 18 | 2018 | 6 | |
| 19 | 2012 | 5 | |
| 20 | 2024 | 3 |
About Xiaozhen Lin
Xiaozhen Lin is a scholar working on Molecular Biology, Neurology, Genetics, Geriatrics and Gerontology and Rheumatology, having authored 29 papers that have together received 490 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (3 papers), Sirtuins and Resveratrol in Medicine (2 papers), Neurological disorders and treatments (2 papers), Neurogenetic and Muscular Disorders Research (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), RNA modifications and cancer (2 papers), Integrated Energy Systems Optimization (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (18 citations), Energy Engineering and Power Technology (18 citations), Biochemistry (29 citations), Cancer Research (66 citations) and Genetics (44 citations). Xiaozhen Lin has collaborated with scholars based in China, Taiwan and Australia. Frequent co-authors include Bin Qiao, Baoxia He, Gang Liang, Anzhou Tang, Li Li, Zhiming Huang, Qingdi Quentin Li, Su Zhang, Ziqing Wei and Xiaoqiang Zhai. Their work appears in journals such as Medical Image Analysis, Frontiers in Cardiovascular Medicine, Gene, Aging and Disease and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.